Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AS-Faktor (Lantmännen AS-Faktor AB) is a Swedish biotechnology company and a subsidiary of the Lantmännen Group, specializing in the development and commercialization of products based on the Antisecretory Factor (AF) protein. AF is an endogenous protein that regulates fluid and ion transport across cell membranes and possesses potent anti-inflammatory properties. The company's portfolio includes medical foods such as SPC-Flakes and Salovum, which are used to manage chronic diarrhea, inflammatory bowel disease, and Meniere's disease by inducing or providing AF. Additionally, the company and its affiliate Lantmännen Medical are advancing AF-16, a synthetic peptide derivative, for clinical applications in traumatic brain injury and cerebral edema.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antisecretory Factor.